Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2021.01.052
Abstract: IMPORTANCE Despite approximately 4,400 unresectable U.S. cases annually, high-stage basal cell carcinoma (BCC) is ill-defined. OBJECTIVE Develop a tumor (T) staging system for BCC predicting metastasis/death and compare its performance to AJCC 8th edition (AJCC8)… read more here.
Keywords: death; bwh; risk metastasis; basal cell ... See more keywords
Prostate cancer: Predicting risk of metastasis after prostatectomy
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Urology"
DOI: 10.1038/nrurol.2017.228
Abstract: Safety and efficacy of the anti-PDL1 antibody atezolizumab versus chemotherapy were assessed in the phase III trial IMvigor211 in 931 patients with metastatic urothelial carcinoma who had progressed after platinum-based chemotherapy. In patients with PDL1… read more here.
Keywords: chemotherapy; predicting risk; risk metastasis; prostate cancer ... See more keywords
Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
Sign Up to like & getrecommendations! Published in 2018 at "BMC Cancer"
DOI: 10.1186/s12885-018-5079-x
Abstract: BackgroundGermline mutations in BAP1 have been associated with BAP1-Tumor Predisposition Syndrome (BAP1-TPDS), a predisposition to multiple tumors within a family that includes uveal melanoma (UM), cutaneous melanoma, malignant mesothelioma and renal cell carcinoma. Alternatively, somatic… read more here.
Keywords: bap1; risk metastasis; bap1 mutations; metastasis ... See more keywords